Borsuk S. Technology development and standardization of the new tryptophan and thiotriazoline combined drug

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0419U000531

Thesis Registration Form

0419U000531.pdf

Applicant for

Specialization

  • 15.00.03 - Стандартизація та організація виробництва лікарських засобів

01-02-2019

Specialized Academic Board

Д 64.605.01

National University of Pharmacy

Essay

The work is devoted to the pharmaceutical development and standardization of a new, effective drug based on a fixed combination of L-tryptophan with thiotriazoline. On the basis of the conducted research, a drug master file on L-tryptophan tablets with thiotriazoline was developed

Read more

Files

autoreferat--aref.docx

dis.pdf

Similar theses

0521U101994

Savchenko Lesia Petrivna

Scientific and methodological approaches to quality assurance of compounded ointments

0521U101164

Khromylova Olga Volodymyrivna

Development and standardization of fixed combined neurometabolitotropic cerebroprotectors based on combinations of 1,2,4-triazole derivatives with aliphatic transmitter amino acids

0421U100062

Bovtenko Volodimir Oleksandrovich

Pharmaceutical development and standardization of medicinal products with salbutamol sulfate in the form of metered dose inhalers

0421U100059

Zinchenko Ihor Oleksandrovich

Analytical support for pharmaceutical development, optimization of quality control methods and standardization of the semi-solid preparations with ketoprofen

0519U001760

Zdoryk Oleksandr Anatoliyovych

Methodology approaches formation for the pharmacopoeial standardization of compounded preparations